arXiv · 2112.01081
Matrix metalloproteinases as new targets in Alzheimer's disease: Opportunities and Challenges
Abstract
Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidences of their pathological roles have also been obtained in the last decades, making MMPs attractive therapeutic targets for several diseases. Recent discoveries of their involvement in central nervous system (CNS) disorders, and in particular in Alzheimer's disease (AD), have paved the way to consider MMP modulators as promising therapeutic strategies. Over the past few decades, diverse approaches have been undertaken in the design of
Explore related subjects
Keep this discovery
Pauline Zipfel, Christophe Rochais, Kévin Baranger, Santiago Rivera, Patrick Dallemagne. 2021-12-02. Matrix metalloproteinases as new targets in Alzheimer's disease: Opportunities and Challenges. https://arxiv.org/abs/2112.01081
Cite the original work for its findings. Save a collection to share your selection of sources.